Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity.
The stability of the human immunodeficiency virus type 1 (HIV-1) strain IIIB in drug solutions was studied. The data demonstrate that HIV-1 infectivity can be retained in drug solutions (e.g. , heroin, "Khanka," and "Vint") for long periods of time. This fact must be taken into account when designing health education programs for the prevention of HIV and AIDS in Eastern Europe.
Bobkov
Aleksei F
AF
The D. I. Ivanovsky Institute of Virology, Moscow, Russian Federation. a.bobkov@mail.ru
Selimova
Ludmila M
LM
Khanina
Tatyana A
TA
Zverev
Sergey Y
SY
Pokrovsky
Vadim V
VV
Weber
Jonathan N
JN
Bobkov
Eugene N
EN
Rylkov
Andrey V
AV
D002460:Cell Line; D004340:Drug Contamination; D015658:HIV Infections / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification / Q000472:pathogenicity*; D003932:Heroin; D006801:Humans; D013287:Illicit Drugs; D008694:Methamphetamine; D010207:Papaver; D012996:Solutions; D015819:Substance Abuse, Intravenous / Q000150:complications
D013287:Illicit Drugs; D012996:Solutions; D008694:Methamphetamine; D003932:Heroin